Sign In
Buy ZBH
$84.98
+1.23 (+1.47%)
At Close: Jun 03, 2026
Zimmer (ZBH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31am, Wednesday, 05'th Nov 2025
Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Stree
Zimmer Biomet (ZBH) Q3 Earnings Surpass Estimates
08:45am, Wednesday, 05'th Nov 2025
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.9 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.74 per share a year ago.
Zimmer Biomet Announces Third Quarter 2025 Financial Results
06:30am, Wednesday, 05'th Nov 2025
Third quarter net sales of $2.001 billion increased 9.7% on a reported basis, 8.6% on a constant currency1 basis and 5.0% on an organic constant currency1 basis Third quarter diluted earnings per shar
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Envestnet Asset Management Inc.
03:35am, Monday, 03'rd Nov 2025
Envestnet Asset Management Inc. grew its position in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 2.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
07:30am, Tuesday, 28'th Oct 2025
Prioritized Regulatory Review Process in the U.S. Follows Japan PMDA Approval in September WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medic
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Allspring Global Investments Holdings LLC
03:47am, Friday, 24'th Oct 2025
Allspring Global Investments Holdings LLC trimmed its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 99.5% in the second quarter, according to the company in its most recent filing
Will Zimmer (ZBH) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Thursday, 23'rd Oct 2025
Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zimmer Biomet to Report Q3 Earnings: Here's What to Expect
10:01am, Tuesday, 21'st Oct 2025
ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
07:30am, Tuesday, 21'st Oct 2025
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition of Monogram Technologies WARSAW, Ind., Oct. 21
Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy
04:24am, Sunday, 12'th Oct 2025
Zimmer Biomet Holdings is rated a BUY, driven by innovation momentum and undervalued valuation despite recent stock underperformance. ZBH's 'Magnificent 7' products, strategic acquisitions like Monogr
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
09:36am, Friday, 10'th Oct 2025
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
07:30am, Wednesday, 08'th Oct 2025
Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -
Zimmer Biomet Completes Acquisition of Monogram Technologies
09:00am, Tuesday, 07'th Oct 2025
Transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies, including pathway towards the first fully autonomous robotic technology for orthopedic p
I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance
08:00am, Monday, 06'th Oct 2025
ASHBURN, Va.--(BUSINESS WIRE)--I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet's recent achievement in receiving Japan's Pharmaceutical and Medical Devices Agency (PMDA
Are Investors Undervaluing Zimmer Biomet (ZBH) Right Now?
10:41am, Friday, 03'rd Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
